Skip to main content
. 2022 Sep 24;23(19):11250. doi: 10.3390/ijms231911250

Figure 7.

Figure 7

Gemcitabine, mycophenolate mofetil, and mycophenolic acid can inhibit SADS-CoV replication. (A) The expressions of viral proteins in cells after 48 h SADS-CoV infection with different treatments. (B) The growth kinetics of SADS-CoV in the presence of gemcitabine (6.25 μM), mycophenolate mofetil (12.5 μM), and mycophenolic acid (12.5 μM), respectively. (C) The expression of SADS-CoV RNA in the supernatant at 24 hpi, 36 hpi, and 48 hpi in the presence of indicated compounds. DMSO was added as the positive control. The experiments were repeated at least twice. Error bars represent ±1 SD, * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 by Student’s t-test.